Cargando…
Treat Ankylosing Spondylitis with Methazolamide
Background: Increased bone resorption and new bone information are two characteristics of ankylosing spondylitis (AS). Much evidence has shown that carbonic anhydrase inhibitors can restrain bone resorption. We had detected increased expression of carbonic anhydrase I (CA1) in synovium of patients w...
Autores principales: | Chang, Xiaotian, Yan, Xinfeng, Zhang, Yunzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133847/ https://www.ncbi.nlm.nih.gov/pubmed/21750646 |
Ejemplares similares
-
Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA
por: Sun, Tao, et al.
Publicado: (2023) -
Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis
por: Chang, Xiaotian, et al.
Publicado: (2010) -
Opinion of patients with ankylosing spondylitis on risk factors impairing their quality of life
por: Kucharz, Eugene J., et al.
Publicado: (2012) -
A Case of Paclitaxel-induced Maculopathy Treated with Methazolamide
por: Koo, Nam Kyun, et al.
Publicado: (2012) -
Carbonic anhydrase I (CA1) is involved in the process of bone formation and is susceptible to ankylosing spondylitis
por: Chang, Xiaotian, et al.
Publicado: (2012)